Si-Bone (SIBN) Total Non-Current Liabilities (2017 - 2025)
Si-Bone's (SIBN) quarterly Total Non-Current Liabilities came in at $61.0 million in Q4 2025, down 3.84% year-on-year from $63.5 million in Q4 2024, and down 1.81% quarter-over-quarter from $62.1 million in Q3 2025.
Si-Bone (SIBN) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends
Si-Bone's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $61.0 million for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities fell 3.84% year-over-year to $61.0 million in Q4 2025; TTM through Dec 2025 was $61.0 million, a 3.84% decrease from a year earlier, with the FY2025 full-year figure at $61.0 million, down 3.84% from the prior year.
- Total Non-Current Liabilities fell to $61.0 million in Q4 2025 per SIBN's latest filing, from $62.1 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $63.5 million in Q4 2024 and bottomed at $49.5 million in Q3 2021.
- The 5-year median for Total Non-Current Liabilities is $57.7 million (2023), against an average of $57.6 million.
- Across the five-year window, Total Non-Current Liabilities advanced 11.96% in 2022 and dropped 3.84% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $56.0 million in 2021, then advanced by 5.7% to $59.2 million in 2022, then increased by 3.06% to $61.0 million in 2023, then grew by 3.98% to $63.5 million in 2024, then declined by 3.84% to $61.0 million in 2025.
- Per Business Quant, the three latest SIBN Total Non-Current Liabilities figures stand at $61.0 million (Q4 2025), $62.1 million (Q3 2025), and $60.6 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.02 Mn |
| Sep 30, 2025 | 62.15 Mn |
| Jun 30, 2025 | 60.58 Mn |
| Mar 31, 2025 | 60.02 Mn |
| Dec 31, 2024 | 63.46 Mn |
| Sep 30, 2024 | 62.01 Mn |
| Jun 30, 2024 | 59.10 Mn |
| Mar 31, 2024 | 58.16 Mn |
| Dec 31, 2023 | 61.03 Mn |
| Sep 30, 2023 | 57.26 Mn |
| Jun 30, 2023 | 56.39 Mn |
| Mar 31, 2023 | 55.09 Mn |
| Dec 31, 2022 | 59.22 Mn |
| Sep 30, 2022 | 55.41 Mn |
| Jun 30, 2022 | 55.28 Mn |
| Mar 31, 2022 | 54.37 Mn |
| Dec 31, 2021 | 56.03 Mn |
| Sep 30, 2021 | 49.49 Mn |
| Jun 30, 2021 | 52.25 Mn |
| Mar 31, 2021 | 53.25 Mn |